Get Support

Search global stocks & ETFs...Ctrl K

Learn Mode

ISRG - Intuitive Surgical Inc

468

$450.06

-$3.43 (-0.756%)

At market close

$450.02

-$0.04 (-0.009%)

After Hours 5/8/26, 11:56 PM

3.85/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

ISRG

Valuation Score

View as %

Stock Unlock

1D

1W

1M

YTD

1Y

3Y

5Y

Max

Stock Profile

Market Cap

$159.39B

Industry

Health Care

EPS (TTM)

$7.92

P/E (TTM)

55.81

Div & Yield

--

FCF Payout Ratio

--

P/S (TTM)

15.84

P/B

8.94

Diluted Shares

360.30M

Ex-Dividend

--

Next Earnings

07-20

Forward P/E

42.49

Payout Ratio

--

P/FCF (TTM)

64.00

FCF Yield

1.56%

Earnings Yield

1.79%

52 Week Range

Score Card

Explore Scores Tab

3.85

Good

Intuitive Surgical Inc has grown revenue at 20.51% over the past year, which is strong growth. Also, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.

Valuation Model

Key Score

4.00

Good

Management

3.00

Average

Growth

2.00

Bad

Profitability

1.00

Very Bad

Fin. Health

1.00

Very Bad

Dividends

--

--

Analyst

5.00

Very Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-05-04 16:05:32

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-01 14:35:19

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 21:13:36

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 21:07:59

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 21:02:59

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:56:20

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:51:26

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:44:52

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:36:41

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:21:51

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-30 20:12:12

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-30 11:15:51

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-25

High:

$787.50

75.0%

Avg:

$592.78

31.7%

Low:

$444.40

-1.3%

(% change is relative to the current stock price: $450.06)

Analyst Recommendations

Go to Analyst Tab

3.95

Good

27%

Strong Buy (11)

44%

Buy (18)

27%

Hold (11)

2%

Sell (1)

0%

Strong Sell (0)

About

Website
https://www.intuitive.com/en-us/about-us/company
Address
1020 Kifer Road, Sunnyvale CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1035267

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

IPO Date

2000-06-13

Industry

Health Care

Total Employees

17,021

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services